Industry News

PharmaBioSource Expands its Capabilities

Over the past 15+ years, PharmaBioSource has earned the reputation as one of the premier Life Sciences consulting and real estate firms, primarily focused on pharmaceutical and biotech facility and company acquisitions and divestitures as well as transaction due diligence and investment risk assessments.

Toward its goal of expanding its capabilities to include product-related transactions and consulting, PharmaBioSource has hired Lori A. Hoffman, former Senior Director of Business Development at Sagent Pharmaceuticals. While at Sagent, she was responsible for pipeline strategy, product selection, project partnering and licensing. Drawing on that experience and the rest of her 25+ years in the pharmaceutical industry, working for companies such as AMRI, Regis Technologies, and The Upjohn Company (now Pfizer), Ms. Hoffman and the PharmaBioSource team can facilitate product and portfolio transactions, representing either party to an acquisition, divestiture, or licensing deal. In addition, they provide a wide range of product-related consulting services such as Portfolio Strategy, Make vs. Outsource Decisions, Target Buyer/Seller Identification, Due Diligence on Product Asset Transactions, Manufacturing or Marketing Partner Selection, Market Assessments and Product Valuations.

Please join the PharmaBioSource team in welcoming Ms. Hoffman to our organization. Parties interested in our product-related consulting and transaction services may contact Ms. Hoffman at or by calling 610-293-0900.